Antares Pharma, Inc. (AIS) Reports In-Line Q3 EPS Loss of $0.01
Tweet
Share
E-mailGet Alerts AIS Hot Sheet
Price: $77.61 +1.93%
Financial Fact:
Total Operating Expenses: 11.58M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Total Operating Expenses: 11.58M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Antares Pharma, Inc. (NYSE: AIS) reported Q3 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.85 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
- Jefferies Financial stock slips 3% as Fixed Income, Asset Management revenues fall
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
